No Data
Express News | ACELYRIN Shares Down 6.5% After Co Reiterates Merger With Alumis
Express News | Refile-Buzz-ACELYRIN Slides After Reiterating Merger With Alumis Amid Concentra's Buyout Offer
Acelyrin Falls as Acelyrin Reaffirms Deal Commitment
Acelyrin Says Concentra Indication Not Expected to Result in Superior Proposal
Acelyrin and Alumis: Combined Company to Benefit From Differentiated Late-Stage Portfolio of Therapies and Strong Balance Sheet
ACELYRIN and Alumis Reaffirm Strategic and Financial Rationale of Proposed Merger
and I missed out on all the fun, I'll be back in next week. Good to see you still rocking!!!